Synthesis, crystal structure and initial biological evaluation of the new enantiomerically pure chiral palladium(II) complex trans-bis{endo-(1R)-1,7,7-trimethylbicyclo[2.2.1]-heptan-2-amino}palladium (II)dichloride

European Journal of Medicinal Chemistry

Volumn 37, Issue 11, 2003, Pages 919-922

  Abu Surrah, Adnan S ^a   Al Allaf, Talal A K ^b   Rashan, Luay J ^b   Klinga, Martti ^c   Leskelä, Markku ^c  

^a HASHEMITE UNIVERSITY   (Jordan)

^b APPLIED SCIENCE PRIVATE UNIVERSITY   (Jordan)

^c UNIVERSITY OF HELSINKI   (Finland)

Author keywords

(R) (+) Bornylamine; Anticomplementary; Complexes; Cytotoxicity; Ligand; Trans Palladium(II)

Indexed keywords

CARBOPLATIN; CISPLATIN; COMPLEMENT INHIBITOR; OXALIPLATIN; PALLADIUM COMPLEX; PROTEIN INHIBITOR; ANTINEOPLASTIC AGENT; ORGANOMETALLIC COMPOUND; PALLADIUM;

ARTICLE; ASSAY; COMPLEMENT INHIBITION; CONTROLLED STUDY; CYTOTOXICITY; DRUG STRUCTURE; DRUG SYNTHESIS; FEMALE; HELA CELL; HUMAN; HUMAN CELL; X RAY ANALYSIS; CELL CULTURE; CELL DIVISION; CHEMICAL STRUCTURE; CHEMISTRY; DRUG EFFECT; IC 50; STEREOISOMERISM; SYNTHESIS; X RAY CRYSTALLOGRAPHY;

ANTINEOPLASTIC AGENTS; CELL DIVISION; CRYSTALLOGRAPHY, X-RAY; HUMANS; INHIBITORY CONCENTRATION 50; MOLECULAR STRUCTURE; ORGANOMETALLIC COMPOUNDS; PALLADIUM; STEREOISOMERISM; TUMOR CELLS, CULTURED;

EID: 0037210421     PISSN: 02235234     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0223-5234(02)01415-0     Document Type: Article

References (16)

1. Rau T., van Eldik R. Sigel H., Sigel A., Metal Ions in Biological Systems. 31:1996;339-378 Marcel Dekker, New York.
2. González M.L., Tercero J.M., Matilla A., Niclós-Gutiérrez J., Fernández M.T., López M.C., Alonso C., Gonzálz S. Inorg. Chem. 36:1997;1806-1812.
3. Mansuri-Torshizi H., Srivastava T.S., Parekh H.K., Chitnis M.P. J. Inorg. Biochem. 45:1992;135-140.
4. Wimmer F.L., Wimmer S., Castan P., Cros S., Johnson N., Colacio-Rodrigez E. Anticancer Res. 9:1989;791-794.
5. Zhao G., Lin H., Yu P., Sun H., Zhu S., Su X., Chen Y. J. Inorg. Biochem. 73:1999;145-149.
6. Al-Allaf T.A.K., Rashan L.J. Eur. J. Med. Chem. 33:1998;817-820.
7. T.A.K. Al-Allaf, L.J. Rashan, 37th IUPAC Congress, 14-19 August, Berlin, Germany, 1999.
8. Al-Allaf T.A.K., Rashan L.J. Asian J. Chem. 11:1999;1543-1545.
9. Al-Allaf T.A.K., Rashan L.J. Boll. Chim. Farmac. (Italy). 140:2001;205-210.
10. R.F. Khuzaie, L.J. Rashan, T.A.K. Al-Allaf, Oriental J. Chem. 18 (2002) 1-6.
11. Doyle J.R., Slade P.E., Jonassen H.B. Inorg. Synth. 6:1960;216-219.
12. Molecular Structure Corporation, TEXSAN, Single Crystal Structure Analysis Software, Version 1.6, MSC, 3200 Research Forest Drive, The Woodlands, TX 77381, USA.
13. North A.C.T., Phillips D.C., Mathews F.S. Acta Crystallogr. Sect. A. 24:1968;351-359.
14. G.M. Sheldrick, SHELX-97, Program for the Solution and Refinement of Crystal Structures, University of Göttingen, Germany.
15. G.M. Sheldrick, SHELXTL/PC, Siemens Analytical X-Ray Instruments Inc., Madison, WI, USA.
16. Shahat A.A., Hammouda F., Ismail S.I., Azzam S.A., Bruyne T.D., Lasure A., van Poel B., Pieters L., Vlietinck A.J. Planta Med. 62:1996;10-13.